| Abstrakt: |
BREMEN, Germany, Sept. 26, 2017 /PRNewswire/ -- Bruker today announced the closing of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Germany. MERLIN has in-depth expertise in products, services and consulting in the fields of antibiotic resistance testing (ART) and antibiotic susceptibility testing (AST). MERLIN's technology and product portfolio for human and veterinary antibiotic resistance and specialty susceptibility testing further expands Bruker´s microbiology business, which is based on rapid, broad-based microbial identification using Bruker's market-leading MALDI Biotyper(MBT) platform for proteomic fingerprinting. Financial details were not disclosed. [ABSTRACT FROM PUBLISHER] |
